CJ Surpasses Annual Production of IV Solutions Over 30 Million Units

CJ Pharmaceutical Division achieved its annual production of intravenous (IV) fluid sets and solutions surpassing 30 million units per year, driving the total IV solution revenue of 40 billion won for the current year.

Prior the early 1990’s, the domestic pharmaceutical manufacturers did not show much business interests towards the IV solution market, due to high initial investment outlays r...